ClariVest Asset Management LLC raised its position in Omega Protein Corporation (NYSE:OME) by 1.7% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 291,219 shares of the company’s stock after buying an additional 4,809 shares during the quarter. ClariVest Asset Management LLC owned about 1.30% of Omega Protein worth $4,849,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also recently modified their holdings of OME. Victory Capital Management Inc. grew its position in shares of Omega Protein by 17.6% in the second quarter. Victory Capital Management Inc. now owns 9,234 shares of the company’s stock valued at $165,000 after purchasing an additional 1,384 shares in the last quarter. Eqis Capital Management Inc. purchased a new position in shares of Omega Protein in the second quarter valued at $183,000. AHL Partners LLP purchased a new position in Omega Protein during the second quarter worth about $189,000. Voya Investment Management LLC grew its position in Omega Protein by 16.2% during the second quarter. Voya Investment Management LLC now owns 11,668 shares of the company’s stock worth $209,000 after buying an additional 1,626 shares in the last quarter. Finally, UBS Group AG grew its position in Omega Protein by 191.6% during the first quarter. UBS Group AG now owns 12,575 shares of the company’s stock worth $252,000 after buying an additional 8,262 shares in the last quarter. Hedge funds and other institutional investors own 85.81% of the company’s stock.
Separately, ValuEngine upgraded Omega Protein from a “hold” rating to a “buy” rating in a research report on Friday.
Shares of Omega Protein Corporation (NYSE:OME) remained flat at $$22.00 during mid-day trading on Monday. The stock had a trading volume of 339,657 shares, compared to its average volume of 282,411. Omega Protein Corporation has a 52-week low of $14.50 and a 52-week high of $26.99. The stock has a market cap of $494.54, a P/E ratio of 22.22 and a beta of 0.28.
Omega Protein (NYSE:OME) last released its earnings results on Wednesday, November 8th. The company reported $0.09 earnings per share for the quarter, missing analysts’ consensus estimates of $0.31 by ($0.22). The company had revenue of $90.30 million during the quarter, compared to the consensus estimate of $96.65 million. Omega Protein had a net margin of 5.45% and a return on equity of 6.48%. The company’s revenue was down 17.0% on a year-over-year basis. During the same period last year, the firm posted $0.67 EPS.
COPYRIGHT VIOLATION WARNING: “Omega Protein Corporation (NYSE:OME) Shares Bought by ClariVest Asset Management LLC” was reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this piece of content on another site, it was stolen and reposted in violation of United States & international trademark and copyright laws. The original version of this piece of content can be read at https://www.dispatchtribunal.com/2017/12/04/clarivest-asset-management-llc-has-4-85-million-stake-in-omega-protein-corporation-ome.html.
Omega Protein Profile
Omega Protein Corporation is a nutritional products company that develops, produces and delivers nutritious products. The Company operates through two segments: animal nutrition and human nutrition. The Company’s animal nutrition segment consists of two subsidiaries: Omega Protein, Inc (Omega Protein) and Omega Shipyard, Inc (Omega Shipyard).
Receive News & Ratings for Omega Protein Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Protein Corporation and related companies with MarketBeat.com's FREE daily email newsletter.